You can watch webinar recoding on this link:

The webinar hosted by Prof. Arsia Amir Aslani, Director of the Advanced Master’s Program in Biotechnology & Pharmaceutical Management at Grenoble Ecole de Management (GEM). 

On April 29th, GEM and 41 North Business School jointly organized an EMBA webinar for the prospective participants of the Istanbul Cohort program.

Prof. Aslani,  prominent GEM faculty member, illustrated specific corporate investment models designed to analyze large investment projects in the pharma industry.  His clear presentation was an outstanding example of how GEM trains EMBA participants on the use and interpretation of complex management models.

The top 10 pharma companies of 2019


Participants remarked:

“Thank you (Prof. Aslani) very much. It was great, useful and highly informative even though I was not much familiar with Hi-tech/Pharma business. I really appreciate GEM and 41 North team to set up such a beneficial and up-to-date session.”


“The webinar was very interesting and informative. The content was related to the pharma industry, but Prof. Aslani made it practical and easy to understand. The R&D concept can be applied to projects that I am used to in the mining industry”.


“The overall presentation quality was excellent and was explained by the presenter in a way that could be easily understood by non-finance professionals like myself.”